Terns Pharmaceuticals, Inc.(TERN)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

Terns Pharmaceuticals, Inc. (TERN) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. TERN is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Top institutional holders of TERN by reported 13-F value include BlackRock, MORGAN STANLEY, Avoro Capital Advisors, based on the most recent SEC filings. TERN trades on the Nasdaq exchange and files with the SEC under CIK 1831363. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate TERN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Terns Pharmaceuticals, Inc. directly from SEC EDGAR.

Free Cash Flow

$-19.1M

TERN key financials by period

Terns Pharmaceuticals, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202110-K$1.0M$-50.2M—

Institutions holding TERN

Institutional investors reporting a position in Terns Pharmaceuticals, Inc. on SEC Form 13F.
InstitutionSharesValueReported
BlackRock9,569,585$504.5M2026-03-31
MORGAN STANLEY6,449,140$340.0M2026-03-31
Avoro Capital Advisors5,695,000$300.2M2026-03-31
VANGUARD CAPITAL MANAGEMENT4,355,482$229.6M2026-03-31
Holocene Advisors4,115,828$217.0M2026-03-31
CITADEL ADVISORS3,218,810$169.7M2026-03-31
MILLENNIUM MANAGEMENT3,011,558$158.8M2026-03-31
HBK INVESTMENTS L P2,950,000$155.5M2026-03-31
BALYASNY ASSET MANAGEMENT L.P.2,779,445$146.5M2026-03-31
FRANKLIN RESOURCES2,409,019$127.0M2026-03-31
SEC EDGAR: CIK 1831363 →
TERN

Terns Pharmaceuticals, Inc.

TERN
NasdaqMid CapHealthcare

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

EPS (Diluted)

Q4 2025
EDGAR

$-0.24

ROIC

Q4 2025
EDGAR

-11.0%

Free Cash Flow

Q4 2025
EDGAR

$-19.08M

Top Institutional Holders

as of Q1 2026
$6.78B total
BlackRock, Inc.
$504.51M+16.8%
MORGAN STANLEY
$340.00M-18.8%
Avoro Capital Advisors LLC
$300.24M+30.9%
VANGUARD CAPITAL MANAGEMENT LLC
$229.62MNew
Holocene Advisors, LP
$216.99M+48.3%
CITADEL ADVISORS LLC
$169.70M+3335.2%
MILLENNIUM MANAGEMENT LLC
$158.77M+205.0%
HBK INVESTMENTS L P
$155.52MNew
BALYASNY ASSET MANAGEMENT L.P.
$146.53M+211.6%
FRANKLIN RESOURCES INC
$127.00M-11.8%

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…